- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dihydrouracil Dehydrogenase (NADP)
Total 1140 results
-
AbbVie (prior sponsor, Abbott)CompletedGastric CancerUnited States, Korea, Republic of
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZeneca; MedImmune LLCTerminatedPrimary Peritoneal CarcinomaUnited States
-
Hoosier Cancer Research NetworkClovis Oncology, Inc.CompletedBreast CancerUnited States
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | Small Cell Lung Carcinoma | Prostate Cancer | Ewing Sarcoma | Pancreas Cancer | Ovarian Cancer, Epithelial | Advanced or Recurrent Solid TumorsUnited States, United Kingdom
-
AstraZenecaMyriad Genetic Laboratories, Inc.WithdrawnPlatinum Sensitive Relapsed Ovarian CancerUnited States, Korea, Republic of, Peru, United Kingdom, Philippines
-
SanofiCompletedPrimary Peritoneal Cancer | Advanced Epithelial Ovarian CancerUnited States
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Solid Tumors
-
Inje UniversityCompletedBowel Preparation, Efficacy, Tolerability, SafetyKorea, Republic of
-
Ibrahim Halil SahinGlaxoSmithKlineNot yet recruitingMMR-D/MSI-H Colorectal CancersUnited States
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineRecruitingPenile CarcinomaUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
Tesaro, Inc.Completed
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
AstraZenecaCompletedAdvanced Solid TumorsUnited States, Spain
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingHead and Neck Neoplasms | Carcinoma, Squamous Cell | Laryngeal Cancer Stage II | Laryngeal Cancer Stage IIINetherlands
-
zr Pharma & GmbHCompletedAdvanced Solid TumorsUnited Kingdom
-
University of Alabama at BirminghamWithdrawnOvarian Cancer RecurrentUnited States
-
Geoffrey Shapiro, MD, PhDEli Lilly and Company; AstraZenecaCompletedSolid TumorUnited States
-
PfizerMedivation, Inc.CompletedAdvanced Solid TumorsUnited States, Canada
-
National Cancer Institute (NCI)Terminated
-
Ruijin HospitalUnknownStomach Cancer | Gastric CancerChina
-
AstraZenecaCompletedSolid TumoursBelgium, France, Netherlands, United Kingdom, Denmark
-
Sichuan UniversityRecruitingLung Cancer | Extensive-stage Small-cell Lung CancerChina
-
Sun Yat-sen UniversityNot yet recruitingOvarian Cancer | Primary Peritoneal Cancer | High Grade Serous Adenocarcinoma of Ovary | High Grade Endometrioid Ovarian Cancer | Fallopian-tube CancerChina
-
Marco ValgimigliCompletedCoronary Artery DiseaseItaly
-
Sir Mortimer B. Davis - Jewish General HospitalNot yet recruitingEndometrial Cancer | Uterine Neoplasm | Serous Adenocarcinoma
-
Massachusetts General HospitalPfizer; Prostate Cancer Foundation; Calithera Biosciences, IncNot yet recruiting
-
Stanford UniversityPfizerRecruitingBreast Cancer | Advanced Breast CancerUnited States
-
The University of Hong KongRecruitingRecurrent Glioblastoma | Recurrent Glioma | Poly ADP Ribose Polymerase (PARP) Inhibitor | PTEN Gene Inactivation | IDH MutationHong Kong
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.TerminatedTriple Negative Breast CancerUnited States, Belgium, China, Spain
-
PfizerMedivation, Inc.CompletedProstate CancerAustralia, United States, Spain, France, Korea, Republic of, Germany, Austria, United Kingdom, Belgium, Hungary, Italy, Brazil, Netherlands, Poland
-
Kari WisinskiPfizer; Celcuity IncActive, not recruitingTNBC - Triple-Negative Breast CancerUnited States
-
Tempus AIGlaxoSmithKlineActive, not recruitingMelanoma | Head and Neck Cancer | Pancreatic Cancer | Esophageal Cancer | Solid Tumor | Metastatic Cancer | Endometrial Cancer | Urologic Cancer | Breast Tumor | Locally Advanced Solid Tumor | Lung Tumor | Colon Tumor, MalignantUnited States
-
Vanderbilt-Ingram Cancer CenterAstraZeneca; Syndax PharmaceuticalsTerminatedFallopian Tube Cancer | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Recurrent Endometrial Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Primary Peritoneal... and other conditionsUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedPregnant Women Undergoing TOP | TOP - Failed Attempted Termination of PregnancyFrance
-
The Netherlands Cancer InstituteCompletedLocally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast CarcinomaNetherlands
-
The Netherlands Cancer InstituteAstraZenecaCompleted
-
AHS Cancer Control AlbertaUnknown
-
Haider MahdiGlaxoSmithKline; Zenith EpigeneticsRecruitingOvarian Cancer | Recurrent Solid TumorsUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Xiaoxiang ChenRecruitingNeoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Ovarian Diseases | Adnexal Diseases | Carcinoma, Ovarian Epithelial | Ovarian Cancer | Angiogenesis | Genital Diseases, Female | Antineoplastic Agents | BRCA1... and other conditionsChina
-
University of PennsylvaniaAstraZeneca; Myriad Genetics, Inc.RecruitingHigh Grade Serous CarcinomaUnited States
-
AstraZenecaActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum SensitiveChina, Malaysia
-
Peter MacCallum Cancer Centre, AustraliaSuspendedPidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)Metastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
Melinda TelliPfizer; BioMarin PharmaceuticalCompletedAdvanced Breast Cancer | HER2/Neu Negative | Triple-Negative Breast CancerUnited States
-
Zai Lab (Shanghai) Co., Ltd.TerminatedGastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract CarcinomaChina